标题
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
作者
关键词
-
出版物
MOLECULES
Volume 22, Issue 2, Pages 191
出版商
MDPI AG
发表日期
2017-01-24
DOI
10.3390/molecules22020191
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Adherence to the Mediterranean diet is inversely associated with metabolic syndrome occurrence: a meta-analysis of observational studies
- (2016) Justyna Godos et al. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence
- (2016) Alessandro Federico et al. Translational Research
- Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe
- (2016) Arnolfo Petruzziello et al. Infectious Agents and Cancer
- Mitochondrial proteolysis: Its emerging roles in stress responses
- (2015) Shiori Sekine et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition
- (2015) H.B. Li et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
- (2015) Zobair M. Younossi et al. HEPATOLOGY
- Serum and tissue pharmacokinetics of silibinin after per os and i.v. administration to mice as a HP-β-CD lyophilized product
- (2015) Eirini Christodoulou et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Silymarin Inhibits the Progression of Fibrosis in the Early Stages of Liver Injury in CCl4-Treated Rats
- (2015) Simona Clichici et al. JOURNAL OF MEDICINAL FOOD
- A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients
- (2015) Dominique L. Braun et al. PLoS One
- New silibinin glyco-conjugates: Synthesis and evaluation of antioxidant properties
- (2014) Armando Zarrelli et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Silybin exerts antioxidant effects and induces mitochondrial biogenesis in liver of rat with secondary biliary cirrhosis
- (2014) Gaetano Serviddio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pathological Features of Fatty Liver Disease
- (2014) Matthew M. Yeh et al. GASTROENTEROLOGY
- Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis
- (2014) Christophe Hézode et al. GASTROENTEROLOGY
- Identification of Isosilybin A from Milk Thistle Seeds as an Agonist of Peroxisome Proliferator-Activated Receptor Gamma
- (2014) Eva-Maria Pferschy-Wenzig et al. JOURNAL OF NATURAL PRODUCTS
- Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kinetics
- (2014) Harel Dahari et al. LIVER INTERNATIONAL
- Serum Oxidative Stress Markers and Lipidomic Profile to Detect NASH Patients Responsive to an Antioxidant Treatment: A Pilot Study
- (2014) Paola Stiuso et al. Oxidative Medicine and Cellular Longevity
- US News and World Report Cancer Hospital Rankings: Do They Reflect Measures of Research Productivity?
- (2014) Vinay Prasad et al. PLoS One
- Effects and Tolerance of Silymarin (Milk Thistle) in Chronic Hepatitis C Virus Infection Patients: A Meta-Analysis of Randomized Controlled Trials
- (2014) Zongguo Yang et al. Biomed Research International
- Down-regulation of LPCAT expression increases platelet-activating factor level in cirrhotic rat liver: Potential antiinflammatory effect of silybin
- (2013) Eleonora Stanca et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
- (2013) Jiayin Yao et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking
- (2013) Julie Blaising et al. CELLULAR MICROBIOLOGY
- Is genotype 3 of the hepatitis C virus the new villain?
- (2013) Nicolas Goossens et al. HEPATOLOGY
- Dietary supplementation of silymarin is associated with decreased cell proliferation, increased apoptosis, and activation of detoxification system in hepatocellular carcinoma
- (2013) Ramakrishnan Gopalakrishnan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes
- (2013) Ignazio Grattagliano WORLD JOURNAL OF GASTROENTEROLOGY
- Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B
- (2012) F. Wei et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
- (2012) Carmela Loguercio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure: Results from the REALIZE trial
- (2012) Sandra De Meyer et al. HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Understanding silibinin’s modes of action against HCV using viral kinetic modeling
- (2012) Jeremie Guedj et al. JOURNAL OF HEPATOLOGY
- A 360-degree overview of paediatric NAFLD: Recent insights
- (2012) Valerio Nobili et al. JOURNAL OF HEPATOLOGY
- Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease
- (2012) E.S. Hackett et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not
- (2012) Zobair M. Younossi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Biochemical and immunological basis of silymarin effect, a milk thistle (Silybum marianum) against ethanol-induced oxidative damage
- (2012) Subir Kumar Das et al. TOXICOLOGY MECHANISMS AND METHODS
- Intravenous silibinin as ‘rescue treatment’ for on-treatment non-responders to pegylated interferon/ribavirin combination therapy
- (2011) Karoline Rutter et al. ANTIVIRAL THERAPY
- Metabolic effects of silibinin in the rat liver
- (2011) Carina Parisoto Colturato et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
- (2011) Kohichiroh Yasui et al. Clinical Gastroenterology and Hepatology
- Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
- (2011) Michael R. Charlton et al. GASTROENTEROLOGY
- Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease
- (2011) Srinevas K. Reddy et al. HEPATOLOGY
- Silibinin suppresses the maintenance of colorectal cancer stem-like cells by inhibiting PP2A/AKT/mTOR pathways
- (2011) Jir-You Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation
- (2011) Jessica Wagoner et al. PLoS One
- Investigating the Potential for Toxicity from Long-Term Use of the Herbal Products, Goldenseal and Milk Thistle
- (2011) June K. Dunnick et al. TOXICOLOGIC PATHOLOGY
- Silybin and the liver: From basic research to clinical practice
- (2011) Carmela Loguercio WORLD JOURNAL OF GASTROENTEROLOGY
- Suppression of Casein Kinase 1 in Melanoma Cells Induces a Switch in -Catenin Signaling to Promote Metastasis
- (2010) T. Sinnberg et al. CANCER RESEARCH
- Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats
- (2010) Anshu Jain et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection
- (2010) Brad Q. Starley et al. HEPATOLOGY
- Multiple effects of silymarin on the hepatitis C virus lifecycle
- (2010) Jessica Wagoner et al. HEPATOLOGY
- Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy
- (2010) U.P. Neumann et al. JOURNAL OF HEPATOLOGY
- Nonobese individuals in the developing world are at risk of nonalcoholic fatty liver and liver disease
- (2010) Natalie J. Wood Nature Reviews Gastroenterology & Hepatology
- Identification of hepatoprotective flavonolignans from silymarin
- (2010) S. J. Polyak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatoprotective effects of the nitric oxide donor isosorbide-5-mononitrate alone and in combination with the natural hepatoprotectant, silymarin, on carbon tetrachloride-induced hepatic injury in rats
- (2010) Omar Mohamed E. Abdel Salam et al. INFLAMMOPHARMACOLOGY
- PCNA on the crossroad of cancer
- (2009) Ivaylo Stoimenov et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Noreen Hossain et al. Clinical Gastroenterology and Hepatology
- Platelet-Activating Factor Involvement in Thioacetamide-Induced Experimental Liver Fibrosis and Cirrhosis
- (2009) Haralabos C. Karantonis et al. DIGESTIVE DISEASES AND SCIENCES
- Antioxidant and Hepatoprotective Effects of Silibinin in a Rat Model of Nonalcoholic Steatohepatitis
- (2009) Yara Haddad et al. Evidence-based Complementary and Alternative Medicine
- Silibinin and Related Compounds Are Direct Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase
- (2009) Abdelhakim Ahmed–Belkacem et al. GASTROENTEROLOGY
- Inflammation and endoplasmic reticulum stress in obesity and diabetes
- (2009) G S Hotamisligil INTERNATIONAL JOURNAL OF OBESITY
- Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C
- (2009) Roy L. Hawke et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
- (2009) Marco Trappoliere et al. JOURNAL OF HEPATOLOGY
- Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive−Compulsive Disorder
- (2009) Mehdi Sayyah et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Causes and Metabolic Consequences of Fatty Liver
- (2008) Norbert Stefan et al. ENDOCRINE REVIEWS
- Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation
- (2008) Majid Momeny et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy
- (2008) Peter Ferenci et al. GASTROENTEROLOGY
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
- Interrelation between the inhibition of glycolytic flux by silibinin and the lowering of mitochondrial ROS production in perifused rat hepatocytes
- (2008) Dominique Detaille et al. LIFE SCIENCES
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
- (2008) N. Anderson et al. PHARMACOLOGICAL REVIEWS
- Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis
- (2008) Yin-Ying Lu WORLD JOURNAL OF GASTROENTEROLOGY
- An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
- (2008) R. Saller et al. FORSCHENDE KOMPLEMENTARMEDIZIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation